Memory Loss Supplement Prevagen Fights For Forgotten Loved Ones

Feb. 11, 2010 - PRLog -- Madison, WI – Memory Loss (http://prevagen.com/MemoryLoss.html)  supplement, Prevagen®, fights for the forgotten loved ones of those whose memory is fading, announcing their continued commitment to research related to neurodegenerative disorders in 2010.

February is the month of hearts and Valentines and remembering those we love, but for the aging baby boom population, it can be a heart breaking time when loved ones have difficulty remembering.   Recall difficulties can be as simple as not remembering what day of the week it is or as severe as not knowing family and friends. This can be painful not only to the person who can’t remember, but also to the person not remembered.  How many wives who didn’t receive a Valentine or anniversary gift thought their husbands no longer loved them when memory loss was the real culprit?

Motivated by his own family experiences with neurodegenerative conditions, Mark Underwood (http://www.quincybioscience.com/management.html), as an undergraduate at the University of Wisconsin-Milwaukee, came across research linking stings of a jellyfish with the symptoms of multiple sclerosis. After several years of research isolating the jellyfish protein called apoaequorin and proving it could protect brain cells, Prevagen was created.

“In quality of life studies, we have shown Prevagen can help reduce forgetfulness, reduces the need for reminders and improves with short-term memory. We understand how vitally important this is to not only to those having memory difficulties, but their loved ones as well,” says Underwood.  “We are continuing our extensive research related to health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products throughout 2010.”

# # #

Memory loss (http://prevagen.com/MemoryLoss.html) supplement researcher Quincy Bioscience, (http://www.quincybioscience.com), is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for use in dietary supplements and pharmaceutical products. The company’s first product, Prevagen was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

* These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.